Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 22,859,000 | 19,960,000 | 18,790,000 | 18,380,000 | 17,444,000 |
| Cost of Goods | 4,500,000 | 4,426,000 | 4,581,000 | 4,508,000 | 4,639,000 |
| Gross Profit | 18,359,000 | 15,534,000 | 14,209,000 | 13,872,000 | 12,805,000 |
| Operating Expenses | 10,822,000 | 12,123,000 | 8,545,000 | 8,055,000 | 9,185,000 |
| Operating Income | 7,537,000 | 3,411,000 | 5,664,000 | 5,817,000 | 3,620,000 |
| Interest Expense | 686,000 | 391,000 | 278,000 | 84,000 | -20,000 |
| Other Income | -206,000 | -651,000 | -54,000 | -8,000 | 28,000 |
| Pre-tax Income | 6,645,000 | 2,369,000 | 5,332,000 | 5,725,000 | 3,668,000 |
| Income Tax | 1,501,000 | 595,000 | 1,204,000 | 450,000 | 235,000 |
| Net Income Continuous | 5,144,000 | 1,774,000 | 4,128,000 | 5,275,000 | 3,433,000 |
| Net Income | $5,144,000 | $1,774,000 | $4,128,000 | $5,275,000 | $3,433,000 |
| EPS Basic Total Ops | 3.15 | 1.11 | 2.58 | 3.35 | 2.18 |
| EPS Basic Continuous Ops | 3.17 | 1.11 | 2.60 | 3.35 | 2.18 |
| EPS Diluted Total Ops | 3.13 | 1.10 | 2.56 | 3.35 | 2.18 |
| EPS Diluted Continuous Ops | 3.14 | 1.10 | 2.57 | 3.35 | 2.18 |
| EBITDA(a) | $8,373,000 | $4,197,000 | $6,561,000 | $6,967,000 | $4,892,000 |